Orthopaedic Product News & Orthopaedic Press Releases | Orthogate Professionals

Caesarea, Israel-based Mazor Robotics' full-year 2016 revenue rose 39 percent to $36.4 million, up from $26.1 million in 2015.

Plainsboro, N.J.-based Integra LifeSciences made a binding offer to acquire Johnson & Johnson's Codman Neurosurgery business, based in Raynham, Mass.

---

Huntley, Ill-based Life Spine reported 2016 revenues increased by 38 percent from 2015 revenues.

The Economic Development Growth Engine for Memphis and Shelby County board approved a $9 million, 11-year payment-in-lieu-of-taxes incentive for San Diego-based NuVasive to create new jobs in the area.

Malden, Mass.-based AxioMed reported positive results for the first patient undergoing a viscoelastic four-level cervical procedure.

Lima Corporate is very proud to announce the arrival of a new Advisory Board Member

UDINE, Italy, Jan. 16, 2017 /CNW/ - Starting January 1^st, Mr. Bruno A. Melzi has joined the Lima organization as an Advisory Board Member. Mr. Melzi joined Zimmer Inc. in 1990 as Managing Director for Italy, from 1997 to 2000 he served as Vice President Europe to become President for EMEA from 2000 to 2003. From this year till 2005 he was Chairman International EMEA & Japan with the direct report of finance, human resources, legal and communications functions. From 2005 to 2013 Mr. Melzi was Chairman for Zimmer EMEA.

The Indian medical device industry is disarray. Even industry representatives admit so. For instance, Rajiv Nath, the forum coordinator of the Association of Indian Medical Device Industry, goes so far as to state that the sector is “in a state of complete mess”.

That’s because about 99% of medical devices such as ultrasound machines, glucometers, endoscopes and ventilators are not regulated by the government. To remedy this, the Ministry of Health and Family Welfare in October made a revised draft of the Medical Device Rules public for comment. However, though there are over 5,000 kinds of medical devices in the market, the draft rules cover only about 20 devices – stents, orthopedic implants, ocular lenses, condoms, sutures and surgical dressings – that have been notified under the Drugs and Cosmetics Act, 1940.

BELGRADE, Mont., Jan. 13, 2017 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE MKT:XTNT), a leader in the development, manufacturing and marketing of orthopedic products for domestic and international markets, today has announced that it has entered into an agreement with certain holders of its convertible promissory notes (“Indenture Notes”) to purchase shares of Xtant's common stock in a registered direct offering conducted without an underwriter or placement agent (the "Offering").

All of the proceeds of the Offering will be applied to set off interest owed by Xtant under certain of the Indenture Notes to the purchasers of the common stock.

 A 3D scaffold has been molded into the precise shape of a hip joint. The scaffold is covered with cartilage made from stem cells taken from fat beneath the skin. (Credit: Guilak laboratory)
Scientists are developing a way to treat arthritic hips without extensive surgery to replace them. They’ve programmed stem cells to grow new cartilage on a 3D template shaped like the ball of a hip joint.

What’s more, using gene therapy, they have activated the new cartilage to release anti-inflammatory molecules to fend off a return of arthritis.

The discovery may one day provide an alternative to hip-replacement surgery, particularly in younger patients.

Orthopedic oncology accounts for a small proportion in orthopedics. Orthopedic oncology is a condition that arises due to the formation of benign and malignant tumors in bones and connective soft tissues. It also includes the diagnosis and treatment of patients with metastatic carcinomato the skeleton. Bone and soft tissue tumors are quite rare and sometimes require reconstructive surgery. Soft tissue sarcomas are more common than bone sarcomas.

There is an increasing focus on alternative payment models for orthopaedic episodes of care. These models advance the goal of improving quality for Medicare beneficiaries and encourage collaboration throughout the full episode of care. CJR is a bundled paymentarrangement for 67 U.S. markets for total hip or total knee replacement surgeries, which are among the most common surgeries covered by Medicare. The SHFFT model is also a bundled payment arrangement for hospitals and clinicians that provides care to patients who receive surgery after a hip fracture. Approximately 258,000 people aged 65 and older were admitted for hip fractures in 2010¹. The estimated lifetime cost for all hip fractures in a single year is $20 billion².